The Cigna Group
CI
$271.63
-$9.64-3.43%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 273.85B | 267.09B | 261.19B | 254.45B | 246.15B |
| Total Other Revenue | 1.05B | 984.00M | 836.00M | 921.00M | 973.00M |
| Total Revenue | 274.90B | 268.08B | 262.02B | 255.37B | 247.12B |
| Cost of Revenue | 249.34B | 242.47B | 236.19B | 229.18B | 221.16B |
| Gross Profit | 25.56B | 25.61B | 25.83B | 26.19B | 25.96B |
| SG&A Expenses | 13.62B | 13.99B | 14.35B | 14.70B | 14.57B |
| Depreciation & Amortization | 1.74B | 1.70B | 1.70B | 1.70B | 1.70B |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 264.70B | 258.16B | 252.25B | 245.58B | 237.43B |
| Operating Income | 10.20B | 9.91B | 9.78B | 9.78B | 9.69B |
| Income Before Tax | 7.78B | 7.97B | 6.87B | 6.84B | 5.27B |
| Income Tax Expenses | 1.49B | 1.42B | 1.47B | 1.44B | 1.49B |
| Earnings from Continuing Operations | 6.29K | 6.55K | 5.40K | 5.40K | 3.78K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -331.00M | -403.00M | -384.00M | -365.00M | -344.00M |
| Net Income | 5.96B | 6.15B | 5.02B | 5.03B | 3.43B |
| EBIT | 10.20B | 9.91B | 9.78B | 9.78B | 9.69B |
| EBITDA | 12.98B | 12.61B | 12.43B | 12.49B | 12.47B |
| EPS Basic | 22.34 | 22.79 | 18.42 | 18.17 | 12.32 |
| Normalized Basic EPS | 19.37 | 18.22 | 17.67 | 17.42 | 17.15 |
| EPS Diluted | 22.19 | 22.66 | 18.31 | 18.05 | 12.23 |
| Normalized Diluted EPS | 19.24 | 18.12 | 17.55 | 17.30 | 17.05 |
| Average Basic Shares Outstanding | 1.07B | 1.08B | 1.09B | 1.11B | 1.12B |
| Average Diluted Shares Outstanding | 1.07B | 1.09B | 1.10B | 1.12B | 1.13B |
| Dividend Per Share | 6.04 | 5.93 | 5.82 | 5.71 | 5.60 |
| Payout Ratio | 27.04% | 26.01% | 31.63% | 31.35% | 45.63% |